Edo Kaluski, MD, FACC, FESC, FSCAI

  • Clinical Details
  • Education
  • News & Video
  • Clinical Trials
  • Briefs & Publications
Clinical Interests: 
  • Coronary Heart Disease
  • Heart Failure
  • Interventional Cardiology
  • Peripheral Vascular Procedures
  • TAVR
Certification: 
  • Cardiovascular Disease, Interventional Cardiology
Education: 
  • Ben-Gurion University Medical School, Beer-Sheva, Israel
Internship: 
  • Rambam University Medical Center, Bat-Galim, Haifa, Israel (Internal Medicine)
Residency: 
  • Morristown Memorial Hospital, Morristown, N.J. (Internal Medicine)
Fellowship: 
  • Tel-Aviv Medical Center, Tel-Aviv, Israel (Clinical Cardiology)
  • Albert Einstein College of Medicine, Bronx, N.Y. (Interventional Cardiology)
Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Janssen
Indentifier #: NCT01830543
Title:
Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Janssen
Indentifier #: NCT01830543
Title: An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention, PIONEER AF-PCI
Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Astra Zeneca
Indentifier #: NCT01866904
Title: TIGRIS: Long-Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease in post myocardial infarction patients
Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Astra Zeneca
Indentifier #: NCT01866904
Title: TIGRIS: Long-Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease in post myocardial infarction patients
Department: Cardiology
Diagnosis: Cardiac - Coronary Artery Disease
Principal Investigator: Kaluski MD, Edo
Sub-Investigator(s):
Sponsor: Janssen
Indentifier #: NCT01830543
Title: An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention, PIONEER AF-PCI

Publications